Search
for

    Research 10 of 1000+

    1. Phase I Clinical Trial: Evaluating the Efficacy, Safety, and Patient Satisfaction of Platelet‐Rich Plasma (PRP) Injections and Microneedling for Androgenetic Alopecia Treatment Journal of Cosmetic Dermatology · 2025
    2. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome European journal of cancer · 2016 · 294 citations
    3. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata Dermatology and Therapy · 2025
    4. 42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials Journal of the American Academy of Dermatology · 2023
    5. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia Journal of Nutrition Health & Aging · 2013 · 211 citations
    6. 519 Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes 2017 · 5 citations
    7. Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial American Journal of Clinical Dermatology · 2024 · 4 citations
    8. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss. PubMed · 2016 · 1 citations
    9. Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2026
    10. 281 Phase I/IIa clinical trial for the treatment of androgenetic alopecia using intradermal injections of cultured autologous dermal sheath cup cells Journal of Investigative Dermatology · 2017
    All research results →

    Community 10 of 420

    1. Hair Regrowth Following a Wnt- and Follistatin- Containing Treatment: Safety and Efficacy in a First-in-Man Phase 1 Clinical Trial: Scientific, Peer-Reviewed Dermatology Article Indexed with MEDLINE/PubMed Reddit · 4 Jun 2014
    2. Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says Reddit · 26 Jan 2026
    3. Verteporfin Phase 1 Human Clinical Trial In The Works Community · 1 Jan 2025
    4. Pyrilutamide phase III clinical trial results released Reddit · 27 Nov 2023
    5. Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy Reddit · 24 Jun 2025
    6. Verteporfin Phase 1 Human Clinical Trial In The Works - Research Reddit · 1 Jan 2025
    7. Pyrilutamide cleared for phase 3 clinical trial in china Reddit · 24 Nov 2021
    8. Han Bio Aims for Phase 1 Clinical Trials in 2027 after successful hair growth in mice Reddit · 18 Apr 2025
    9. Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov Reddit · 24 Jun 2023
    10. Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reddit · 22 Aug 2023
    All community results →

    Learn 10 of 27

    1. PP405 mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
    2. Follistatin Protein that blocks activin, a growth-regulating signal
    3. Finasteride Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically
    4. HMI-115 Experimental antibody that blocks the prolactin receptor
    5. Pyrilutamide Experimental topical anti-androgen, also known as KX-826
    6. Baricitinib JAK inhibitor pill used for severe alopecia areata
    7. GT20029 Experimental topical drug designed to break down androgen receptors
    8. SCUBE3 Signalling protein made in the hair follicle
    9. Rapamycin Immune-suppressing drug, also called sirolimus
    10. Alopecia Areata autoimmune disorder causing patchy hair loss
    All learn results →